Clinical Trial Update: VAXCHORA Pediatric Study to Assess Safety and Immunogenicity [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and immunogenicity results for VAXCHORA in pediatric participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Vaxchora (Vibrio cholerae live attenuated vaccine (strain CV103-HGR))

Snippet

Sponsor: Bavarian Nordic | Conditions: Cholera (Disorder) | Phase 4 | Status: COMPLETED | Results posted: 2020-11-19